Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mycenax Biotech

Mycenax Biotech
2001 FOUNDED
PUBLIC STATUS
51-60 EMPLOYEES
4726 STOCK SYMBOL
$0.70 SHARE PRICE (As of Friday Closing)
Description

Mycenax Biotech Inc is a Taiwan based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company's pipeline products include TuNEX(opinercept - lyophilizate), TuNEX(opinercept - solution), LusiNEX (tocilizumab), and Omalizumab.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
  • Research Zhunan Road
  • 4th Floor, 50-7 Keyan Road
  • Zhunan, Miaoli County 350-53
  • Taiwan

+886 03 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mycenax Biotech’s full profile, request a free trial.

Mycenax Biotech Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.65 - $0.97 $89.7M $0.71 -$0.07 232K 128M

Mycenax Biotech Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 75,355 79,461 75,886 90,982
Revenue 11,153 7,008 10,452 6,191
EBITDA (5,474) (6,976) (4,845) (3,821)
Net Income (8,655) (9,097) (6,179) (4,891)
Total Assets 47,104 36,580 44,228 42,792
Total Debt 1,635 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mycenax Biotech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mycenax Biotech‘s full profile, request access.

Request full access to PitchBook

Mycenax Biotech Executive Team (1)

Name Title Board
Seat
Contact
Info
Karen Wen Founder & President